Locally advanced gastric cancer
Conditions
Interventions
Laparoscopic radical surgery for gastric cancer was performed:Laparoscopic completion of radical gastrectomy for gastric cancer
The method of radical surgery for gastric cancer by robot was adopted:The robot performed a radical gastrectomy for gastric cancer
Sponsors
The First Affiliated Hospital of Army Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Age >18 years, <75 years; 2. The primary lesion in the stomach was diagnosed as gastric adenocarcinoma (papillary adenocarcinoma, tubular adenocarcinoma, mucinous adenocarcinoma, signet ring cell carcinoma, poorly differentiated adenocarcinoma, etc.) through endoscopic biopsy and histopathological examination; 3. Preoperative clinical stage was that of locally advanced gastric cancer (cT2-4a, N0-3, M0, according to the AJCC-8th TNM tumor staging); 4. Preoperative examination revealed no distant metastasis, and the tumor did not directly invade the pancreas, spleen or other adjacent organs; 5. Preoperative ECOG physical condition score: 0/1; 6. Preoperative ASA score: I - III; 7. Agree to participate in this study and sign the informed consent form;
Exclusion criteria
Exclusion criteria: 1.Previous surgery for gastric malignancy, including submucosal resection and/or endomucosal resection; 2.Previous history of upper abdominal surgery (except laparoscopic cholecystectomy); 3.Preoperative imaging examinations indicated regional fusion and enlarged lymph nodes (maximum diameter =3cm); 4.Patients undergo emergency surgery due to bleeding or perforation of gastric tumors; 5.The patient has received definitive therapy before, such as radiotherapy, chemotherapy or immunotherapy; 6.The patient has a history of malignant tumors, or preoperative examination finds that it is combined with other malignant tumors; 7.ASA> Level 3; 8.Severe mental illness; 9.History of unstable angina or myocardial infarction within 6 months; 10.History of cerebral infarction or cerebral hemorrhage within 6 months; 11.Severe lung diseases with FEV1<50%; 12.Continuous systematic treatment with glucocorticoids within 1 month before the study; 13.Concurrent surgical treatment of other diseases is required; 14.Pregnant and lactating women;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Three-year disease-free survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time of operation;Incidence of postoperative complications;The incidence of intraoperative complications;Operative actual;3-year overall survival rate;First time getting out of bed for activities, starting to pass gas, resuming solid food, resuming semi-solid food.;Number of lymph node dissections; | — |
Countries
China
Contacts
Public ContactShi Yan
The First Affiliated Hospital of Army Medical University
Outcome results
None listed